Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial

Biomarkers for selecting gastric cancer (GC) patients likely to benefit from sequential paclitaxel treatment followed by fluorinated-pyrimidine-based adjuvant chemotherapy (sequential paclitaxel) were investigated using tissue samples of patients recruited into SAMIT, a phase III randomized controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Takashi, Tsuburaya, Akira, Yoshida, Kazuhiro, Yoshikawa, Takaki, Miyagi, Yohei, Rino, Yasushi, Masuda, Munetaka, Guan, Jia, Tan, Patrick, Grabsch, Heike I., Sakamoto, Junichi, Tanaka, Shiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123164/
https://www.ncbi.nlm.nih.gov/pubmed/35595817
http://dx.doi.org/10.1038/s41598-022-12439-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123164/
https://www.ncbi.nlm.nih.gov/pubmed/35595817
http://dx.doi.org/10.1038/s41598-022-12439-3

Ejemplares similares